Advertisement

Immunological Studies in Schizophrenia

Critical Analysis of Data Obtained
  • G. Kolyaskina
  • T. Sekirina
  • T. Voronkova
  • T. Micheeva
  • M. Shchurin
  • A. Ivanushkin
  • P. Morozov
  • M. Tsutsulkovskaya

Abstract

This chapter presents the current state of knowledge, the problems and prospects of immunological research into schizophrenia.

Keywords

Blood Lymphocyte Schizophrenic Patient Psychotropic Drug Immunological Study Immunological Parameter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bech, P., Gastpar, M., and Morozov, P., 1984, Clinical assessment scale for biological psychiatry to be used in WHO studies, Prog. Neuropsychopharmacol. Biol. Psychiatry 1: 190–197.CrossRefGoogle Scholar
  2. Bessler, H., Eviator, J., Meshulam, M., ‘I’ano, S., Djaldetti, M., and Sirota, P., 1987, Theophyllinesensitive T-lymphocyte subpopulation in schizophrenic patients, Biol. Psychiatry 22: 1025–1028.PubMedCrossRefGoogle Scholar
  3. DeLisi, L., Goodman, S., Neckers, L., and Wyatt, R., 1982, An analysis of lymphocyte subpopulations in schizophrenic patients, Biol. Psychiatry 17: 1003–1007.PubMedGoogle Scholar
  4. Ganguli, R., Rabin, B., Raghu, U., and Ulrich, R., 1987, T-lymphocytes in schizophrenics and normals and the effects of varying antipsychotic dosage, in: Viruses, Immunity and Mental Disorders ( E. Kurstak, Z. Lipowski, and P. Morozov, eds.), Plenum Medical, New York, pp. 321–326.Google Scholar
  5. Hirata-Hibi, M., Higashi, S., Tachibana, T., and Watanabe, W, 1982, Stimulated lymphocytes in schizophrenia, Arch. Gen. Psychiatry 39: 82–87.PubMedCrossRefGoogle Scholar
  6. Hirata-Hibi, M., Miyauchi, K., and Tachibana, T., 1987, Evidence of lymphocyte abnormality in schizophrenia, in: Viruses, Immunity and Mental Disorders ( E. Kurstak, Z. Lipowski, and P. Morozov, eds.), Plenum Medical, New York, pp. 327–341.Google Scholar
  7. Kolyaskina, G., 1967, The study of sensitivity of schizophrenic patients by the method of lymphocyte cultivation, Korsakoff J. Neuropathol. Psychiatry USSR 2: 284–288.Google Scholar
  8. Kovaleva, E., Bonarcev, P, and Prilipko, L., 1977, Lymphocyte reaction in schizophrenic patients to the phytomitogens: phytohemagglutinin and concanavalin A, Bull. Exp. Biol. Med. (USSR) 84: 182–185.Google Scholar
  9. Kronfol, Z., Silva, J., Greden, J., Dembinski, I., Gardner, R., and Carroll, B. I., 1983, Impaired lymphocyte function in depressive illness, Life Sci. 33: 241–247.PubMedCrossRefGoogle Scholar
  10. Kronfol, Z., lamer, R., Nasrallah, H., and Winokur, G., 1984, Leucocyte regulation in depression and schizophrenia, Psychiatr. Res. 13: 13–18.CrossRefGoogle Scholar
  11. Kurstak, E., Lipowski, Z., and Morozov, P. (eds.), 1987, Viruses, Immunity and Mental Disorders, Plenum Medical, New York.Google Scholar
  12. Liedeman, R., and Prilipko, L., 1978, The behavior of T lymphocytes in schizophrenia, in: Neuro-chemical and Immunological Components in Schizophrenia ( D. Bergsma and A. Goldstein, eds.), Liss, New York, pp. 365–377.Google Scholar
  13. Morozov, P. (ed.), 1983, Research on the Viral Hypothesis of Mental Disorders, Karger, Basel. Morozov, P., 1985, Training models in biological psychiatry and psychopharmacology: WHO experience, Prog. Neuropsychopharmacol. Biol. Psychiatry 3: 334–340.Google Scholar
  14. Pivovarova, A., and Kolyaskina, G., 1980, The different phytohemagglutinin doses action on the blood lymphocyte proliferation in schizophrenia, Bull. Exp. Biol. Med. (USSR) 11: 552–554.Google Scholar
  15. Surman, O., Williams, J., Sheehan, D., Strom, T., Jones, K., and Coleman, J., 1986, Immunological response to stress in agoraphobia and panic attacks, Biol. Psychiatry 21: 768–774.PubMedCrossRefGoogle Scholar
  16. Vartanian, M., Kolyaskina, G., Lozovsky, D., Burbaeva, G., and Ignatov, S., 1978, Aspects of humoral and cellular immunity in schizophrenia, in: Neurochemical and Immunological Components in Schizophrenia ( D. Bergsma and A. Goldstein, eds.), Liss, New York, pp. 339–364.Google Scholar
  17. Zarrabi, M., Zuker, S., Miller, E, Derman, R., Romano, G., Hartnett, I., Varma, A., 1979, Immunologic and coagulation disorders in chlorpromazine treated patients, Ann. Intern. Med. 91: 194–199.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • G. Kolyaskina
    • 1
  • T. Sekirina
    • 1
  • T. Voronkova
    • 1
  • T. Micheeva
    • 1
  • M. Shchurin
    • 1
  • A. Ivanushkin
    • 1
  • P. Morozov
    • 1
  • M. Tsutsulkovskaya
    • 1
  1. 1.Union Mental Health Research Center of the USSR Academy of Medical SciencesMoscowUSSR

Personalised recommendations